Chris van Ingen, the head of Agilent Technologies’ Life Sciences and Chemical Analysis business unit, told analysts last week that there is a “resurgence” in DNA analysis based on the use of microarrays for comparative genomic hybridization and location analysis. And, according to van Ingen, such applications will drive short-term growth for the life science segment of the LSCA unit, which sells genomics, proteomics, and pharmaceutical analysis tools.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.